Skip to main content

Table 2 Screening practice for second primary cancer among cancer survivors

From: Mode of primary cancer detection as an indicator of screening practice for second primary cancer in cancer survivors: a nationwide survey in Korea

  Stomach Cancer Survivors* Lung Cancer Survivors Liver Cancer Survivors Colorectal Cancer Survivors* Breast Cancer Survivors* Cervical Cancer Survivors* Other Cancer Survivors All Survivors
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Men Women Men Women Men Women Men Women N = 113 N = 14 Men Women N = 512
N = 81 N = 25 N = 25 N = 14 N = 30 N = 12 N = 51 N = 23 N = 63 N = 61
Stomach cancer screening NA NA 16 (64.0) 12 (85.7) 12 (40.0) 5 (41.7) 19 (37.3) 8 (34.8) 55 (48.7) 5 (35.7) 30 (47.6) 32 (52.5) 194 (37.9)
Colorectal cancer screening** 32 (47.1) 8 (47.1) 13 (54.2) 9 (69.2) 16 (47.5) 3 (25.0) NA NA 32 (43.8) 5 (38.5) 23 (39.7) 23 (51.1) 164 (39.2)
Breast cancer screening*** NA 12 (48.0) NA 8 (57.1) NA 6 (50.0) NA 8 (34.8) NA 6 (42.9) NA 36 (59.0) 76 (29.0)
Cervical cancer screening*** NA 14 (56.0) NA 9 (64.3) NA 5 (41.7) NA 9 (39.1) 69 (61.1) NA NA 34 (55.7) 140 (53.4)
Complete cancer screening 45 (55.6) 9 (36.0) 14 (56.0) 6 (42.9) 10 (33.3) 3 (25.0) 19 (37.3) 6 (26.1) 27 (23.9) 4 (28.6) 21 (33.3) 25 (41.0) 189 (36.9)
  1. Abbreviations: NA not applicable, N number.
  2. *Only patients not having the specific type of cancer were included for the cancer screening, e.g. stomach cancer survivors were not subject to stomach cancer screening, etc.
  3. **The overall rate of colorectal cancer screening has been calculated only among subjects of age 50 or more (N = 418). Cancer survivors who were younger than 50 were automatically classified as having completed colorectal cancer screening, because they were not recommended to be screened for colorectal cancer by current guidelines. Hence, male stomach cancer survivors younger than 50 were automatically classified as having completed all appropriate SPC screening without having received any screening exam.
  4. ***The overall rates of breast cancer screening and cervical cancer screening have been calculated only among female subjects (N = 262).